Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Alimera Sciences Inc

+ Add to Watchlist

ASZ:GR

4.645 EUR 0.004 0.09%

As of 13:50:36 ET on 02/26/2015.

Company Profile for Alimera Sciences Inc (ASZ)

Alimera Sciences Inc. is a biopharmaceutical company. The Company researches, develops and commercializes prescription ophthalmic pharmaceuticals. Alimera Sciences is focused on diseases affecting the lining in the back of the eye, or retina.

Contact Information

Alimera Sciences Inc

6120 Windward Parkway
Suite 290
Alpharetta, GA 30005
United States
Phone: 1-678-990-5740
Fax: 1-678-990-5744

Key Executives for Alimera Sciences Inc (ASZ)

C Daniel Myers "Dan"President/CEO/Co-FounderRichard S Eiswirth Jr "Rick"CFO/COO/Secretary
Kenneth Green "Ken"Senior VP/Chief Scientific OfcrDavid Holland "Dave"Senior VP:Sales & Marketing
Susan CaballaSenior VP:Regulatory AffairsPhilip AshmanSenior VP/Mng Dir:Europe

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil